Cargando…
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation
The inherited bleeding disorder hemophilia A involves the quantitative deficiency of the coagulation cofactor factor VIII (FVIII). Prophylactic treatment of severe hemophilia A patients with FVIII concentrates aims to reduce the frequency of spontaneous joint bleeding and requires personalized tailo...
Autores principales: | Swystun, Laura L, Lillicrap, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046206/ https://www.ncbi.nlm.nih.gov/pubmed/36998673 http://dx.doi.org/10.2147/PGPM.S383221 |
Ejemplares similares
-
Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism
por: Bittar, Luis F., et al.
Publicado: (2015) -
Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc
por: Traets, Marissa J.M., et al.
Publicado: (2020) -
Transgene-host cell interactions mediate significant influences on the production, stability, and function of recombinant canine FVIII
por: Crawford, Bredon, et al.
Publicado: (2015) -
Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors
por: Bravo, M I, et al.
Publicado: (2014) -
Immune complications and their management in inherited and acquired bleeding disorders
por: Arruda, Valder R., et al.
Publicado: (2022)